Treatment of Schistosoma mansoni infection with oxamniquine in Riyadh, Saudi Arabia.
Single dose therapy with oral oxamniquine was given to 107 Saudi patients suffering from schistosomiasis due to Schistosoma mansoni and they were followed for a period of six months. Clinical cure judged by symptomatic improvement and negative stool counts for S. mansoni eggs was achieved in 88.8%. Side effects were minimal and reversible and it is concluded that this form of treatment is successful for the control of S. mansoni infection.
D006801:Humans; D009600:Nitroquinolines / Q000627:therapeutic use*; D010073:Oxamniquine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D012550:Schistosoma mansoni / Q000302:isolation & purification; D012555:Schistosomiasis mansoni / Q000188:drug therapy* / Q000469:parasitology
D009600:Nitroquinolines; D010073:Oxamniquine